4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0001209191-20-054650
President sold 25,000 shares at $100.00 ($2,500,000)
- President acquired 25,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Novak Rodger President | 2020-10-08 | Option exercise | +22,238 | $14.43 | $320,894 | 670,245 | D |
| Novak Rodger President | 2020-10-08 | Sale | −22,238 | $100.00 | $2,223,800 | 648,007 | D |
| Novak Rodger President | 2020-10-09 | Option exercise | +2,762 | $14.43 | $39,856 | 650,769 | D |
| Novak Rodger President | 2020-10-09 | Sale | −2,762 | $100.00 | $276,200 | 648,007 | D |
| Derivatives | |||||||
| Novak Rodger President | 2020-10-08 | Option exercise · Stock Option (Right to Buy) | −22,238 | 193,077 | D | ||
| Novak Rodger President | 2020-10-09 | Option exercise · Stock Option (Right to Buy) | −2,762 | 190,315 | D | ||
| Open-market sales · 25,000 sh · avg $100.00 · $2,500,000 | |||||||
Loading xslF345X03/doc4.xml…